Disease ID | Disease name | Source of annotation with NFKB1 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
PS607594 | IMMUNODEFICIENCY, COMMON VARIABLE | ClinVar, OMIM | link to OMIM | 12 | NFKB1, CD19, IL21, CR2, MS4A1, LRBA, NFKB2, CD81, IKZF1, TNFRSF13C, TNFRSF13B, ICOS |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Pertussis | hsa05133 | 6.46 |
Salmonella infection | hsa05132 | 6.29 |
Shigellosis | hsa05131 | 6.74 |
Legionellosis | hsa05134 | 6.88 |
Pancreatic cancer | hsa05212 | 6.56 |
MAPK signaling pathway | hsa04010 | 4.63 |
cAMP signaling pathway | hsa04024 | 5.05 |
Prostate cancer | hsa05215 | 6.11 |
Pathways in cancer | hsa05200 | 3.98 |
Neurotrophin signaling pathway | hsa04722 | 5.78 |
Osteoclast differentiation | hsa04380 | 5.64 |
HIF-1 signaling pathway | hsa04066 | 5.9 |
NF-kappa B signaling pathway | hsa04064 | 6.21 |
Chemokine signaling pathway | hsa04062 | 5.19 |
Adipocytokine signaling pathway | hsa04920 | 6.6 |
RIG-I-like receptor signaling pathway | hsa04622 | 6.62 |
Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
Leishmaniasis | hsa05140 | 6.32 |
Amoebiasis | hsa05146 | 5.82 |
Epstein-Barr virus infection | hsa05169 | 4.97 |
Toxoplasmosis | hsa05145 | 5.71 |
Influenza A | hsa05164 | 5.21 |
Herpes simplex infection | hsa05168 | 5.08 |
HTLV-I infection | hsa05166 | 4.59 |
Hepatitis C | hsa05160 | 5.68 |
Hepatitis B | hsa05161 | 5.52 |
Measles | hsa05162 | 5.6 |
Epithelial cell signaling in Helicobacter pylori infection | hsa05120 | 6.58 |
Apoptosis | hsa04210 | 6.23 |
MicroRNAs in cancer | hsa05206 | 5.38 |
Inflammatory bowel disease (IBD) | hsa05321 | 6.43 |
Toll-like receptor signaling pathway | hsa04620 | 6.0 |
NOD-like receptor signaling pathway | hsa04621 | 6.88 |
Viral carcinogenesis | hsa05203 | 5.08 |
Cytosolic DNA-sensing pathway | hsa04623 | 6.79 |
T cell receptor signaling pathway | hsa04660 | 6.01 |
B cell receptor signaling pathway | hsa04662 | 6.52 |
Ras signaling pathway | hsa04014 | 4.9 |
Prolactin signaling pathway | hsa04917 | 6.6 |
Acute myeloid leukemia | hsa05221 | 6.74 |
Chronic myeloid leukemia | hsa05220 | 6.48 |
TNF signaling pathway | hsa04668 | 5.96 |
Transcriptional misregulation in cancer | hsa05202 | 5.21 |
Non-alcoholic fatty liver disease (NAFLD) | hsa04932 | 5.51 |
PI3K-Akt signaling pathway | hsa04151 | 4.21 |
Cocaine addiction | hsa05030 | 7.07 |
Tuberculosis | hsa05152 | 5.17 |
Small cell lung cancer | hsa05222 | 6.17 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
Cellular Senescence | R-HSA-2559583 | 5.7 |
Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.77 |
Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
Immune System | R-HSA-168256 | 2.37 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.34 |
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | R-HSA-168928 | 6.7 |
p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.59 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
Developmental Biology | R-HSA-1266738 | 3.48 |
DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 9.28 |
Signalling by NGF | R-HSA-166520 | 4.23 |
IkBA variant leads to EDA-ID | R-HSA-5603029 | 10.18 |
Signaling by Interleukins | R-HSA-449147 | 4.71 |
Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
Cellular responses to stress | R-HSA-2262752 | 4.56 |
Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
Disease | R-HSA-1643685 | 3.33 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
NF-kB is activated and signals survival | R-HSA-209560 | 9.28 |
ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.28 |
Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.94 |
TCR signaling | R-HSA-202403 | 6.64 |
Interleukin-1 signaling | R-HSA-446652 | 7.52 |
TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.4 |
Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.7 |
Downstream TCR signaling | R-HSA-202424 | 7.01 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
Innate Immune System | R-HSA-168249 | 3.17 |
Regulated proteolysis of p75NTR | R-HSA-193692 | 9.66 |
p75NTR signals via NF-kB | R-HSA-193639 | 8.98 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | R-HSA-445989 | 8.08 |
RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.59 |
Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
Diseases of Immune System | R-HSA-5260271 | 8.34 |
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 9.98 |
MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
CLEC7A/inflammasome pathway | R-HSA-5660668 | 10.4 |
Interleukin-1 processing | R-HSA-448706 | 10.18 |
Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.59 |
MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
Activated TLR4 signalling | R-HSA-166054 | 6.27 |
FCERI mediated NF-kB activation | R-HSA-2871837 | 5.11 |
Signal Transduction | R-HSA-162582 | 1.78 |
Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
GO term | GO ID | GO IC |
---|---|---|
heat shock protein binding | GO:0031072 | 5.24 |
RNA polymerase II regulatory region DNA binding | GO:0001012 | 3.36 |
enhancer sequence-specific DNA binding | GO:0001158 | 5.36 |
macromolecular complex binding | GO:0044877 | 2.61 |
binding | GO:0005488 | 0.18 |
nucleic acid binding | GO:0003676 | 1.44 |
DNA binding | GO:0003677 | 1.92 |
heterocyclic compound binding | GO:1901363 | 1.06 |
sequence-specific DNA binding | GO:0043565 | 2.79 |
sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding | GO:0003705 | 5.23 |
actinin binding | GO:0042805 | 6.3 |
double-stranded DNA binding | GO:0003690 | 3.09 |
identical protein binding | GO:0042802 | 2.63 |
RNA polymerase II distal enhancer sequence-specific DNA binding | GO:0000980 | 5.58 |
transcription factor binding | GO:0008134 | 3.46 |
regulatory region nucleic acid binding | GO:0001067 | 3.03 |
protein homodimerization activity | GO:0042803 | 3.16 |
enhancer binding | GO:0035326 | 5.21 |
transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding | GO:0001205 | 6.48 |
RNA polymerase II transcription factor activity, sequence-specific DNA binding | GO:0000981 | 3.29 |
transcription regulatory region DNA binding | GO:0044212 | 3.03 |
transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding | GO:0001227 | 4.61 |
protein heterodimerization activity | GO:0046982 | 3.64 |
cytoskeletal protein binding | GO:0008092 | 3.02 |
transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
organic cyclic compound binding | GO:0097159 | 1.05 |
transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding | GO:0001228 | 3.98 |
transcription regulatory region sequence-specific DNA binding | GO:0000976 | 3.24 |
RNA polymerase II regulatory region sequence-specific DNA binding | GO:0000977 | 3.37 |
protein binding | GO:0005515 | 0.46 |
regulatory region DNA binding | GO:0000975 | 3.03 |
protein dimerization activity | GO:0046983 | 2.72 |
chromatin binding | GO:0003682 | 3.64 |
nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |